Search by Drug Name or NDC
NDC 49702-0253-15 Cabenuva Details
Cabenuva
Cabenuva is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ViiV Healthcare Company. The primary component is .
Product Information
NDC | 49702-0253 |
---|---|
Product ID | 49702-253_5abcc565-e413-4613-a958-8539df1cfa10 |
Associated GPIs | 1210990225G120 |
GCN Sequence Number | 081857 |
GCN Sequence Number Description | cabotegravir/rilpivirine SUSER VIAL 400-600/2 INTRAMUSC |
HIC3 | W0I |
HIC3 Description | ANTIRETROVIRAL-INTEGRASE INHIBITOR AND NNRTI COMB. |
GCN | 49090 |
HICL Sequence Number | 046258 |
HICL Sequence Number Description | CABOTEGRAVIR/RILPIVIRINE |
Brand/Generic | Brand |
Proprietary Name | Cabenuva |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | cabotegravir and rilpivirine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | ViiV Healthcare Company |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA212888 |
Listing Certified Through | 2024-12-31 |
Package
NDC 49702-0253-15 (49702025315)
NDC Package Code | 49702-253-15 |
---|---|
Billing NDC | 49702025315 |
Package | 1 KIT in 1 CARTON (49702-253-15) * 2 mL in 1 VIAL (49702-245-01) * 2 mL in 1 VIAL (49702-249-02) |
Marketing Start Date | 2021-01-21 |
NDC Exclude Flag | N |
Pricing Information | N/A |